They have been waiting for the Shannon transfer. No new TS hires at MNKD corp. Mannkind Technologies to get going. Wow. This is exciting!
You need to look at the Regenron company for a realistic comparison. Start at the chart in April 15, 2005 as this is about the time SNY partnered with them and I look for similar results here. The share price grew by a factor of 40x.
that is what the math says whether you use discreet or continuous growth compounding. The best thing to do here is leave this board and come back in a year. Go fishing or whatever. I can't believe these shorts have dug themselves this much into a hole. w t f are they going to nefariously, unethically, immorally pull here to cover?!
Director Afrezza International Expansion at Sanofi
Director Professional Marketing, Afrezza at Sanofi
Afrezza Professional Marketing at Sanofi US
Senior Manager, Afrezza Professional Marketing at Sanofi
Director, Diabetes Marketing at Sanofi
Director, Patient Marketing - AFREZZA® at Sanofi
VP, Head of Diabetes Business Unit at Sanofi
Consultant Marketing Director at Valeritas
Senior Director, Diabetes Marketing at Sanofi
Sr. Product Manager - Diabetes at Sanofi
US Afrezza Lead Sanofi
Director, global licenses diabetes at Sanofi
Kathrin Dr. Brodowski
Head Diabetes Portfolio Management & Deputy Strategy & Portfolio Management bei Sanofi
What would happen if a group of outlaws printed money and dumped it into our economy??
Well, if you short/naked short this excessively like they are doing you are devaluing the PPS here. Don't worry. There is at minimum of 20% growth and the these yirks will need to buy back their ill gotten paper gain.
They are just playing a loosing hand of poker at this point. A lot of bravado and no brains.
Like Forest Gump said, "Stupid is stupid does." How will they end up covering with a 20-40% growth rate staring them in the face. Duh...imho
At 7% it takes 10 periods to double. At 40% this is startling.. Sanofi has to be careful here as they could very easily over take production...imho
Once 3q #'s start coming out this is going to be very interesting. The shorts remind me of sitting ducks. Just digging there hole deeper and deeper.
I can here Slim Pickens riding the bomb to give 'em a surprise., yee-haw!
What will be the growth rate when these folks kick into gear with advertising? We are currently at a minimum of 20% growth rate and with IMS # discrepancies could be as high as 40%. SNY certainly has to carefully handle this as it could quickly outpace production. It is little wonder that we are having a controlled launch with growth rates this high.
I did a calculation using a continuous growth exponent form based on the trx initial number of 14 scripts. After 16 weeks and using 20.5% gives a good comparison. Trouble is this does not account for the give away promotional scripts which have a high conversion rate to new patients. Plus IMS numbers seem to be off by a factor of 2 here. SO, the shorts are basically fubared here in a BIG way. lol
I have a spread sheet with i. as the interest variable based on t= weeks.. Interesting stuff when you got excel..imo